Gadopiclenol
VARIOUS
Also known as: elucirem, P03277
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Gadopiclenol is an onp drug catalogued in DrugCentral. It was first approved by the FDA in 2022. Recorded indications include Detect and visualize lesions with abnormal vascularity with MRI.
- Approval status: onp (first approved 2022 by the FDA).
- Indications: Detect and visualize lesions with abnormal vascularity with MRI.
- ATC code: V08CA12 (Paramagnetic contrast media).
- Molecular formula: C35H54GdN7O15; molecular weight 970.10 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Detect and visualize lesions with abnormal vascularity with MRI
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2022-09-21 | FDA | — | GUERBET S.A. |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
V08CA12 | VARIOUS › CONTRAST MEDIA › MAGNETIC RESONANCE IMAGING CONTRAST MEDIA › Paramagnetic contrast media |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Urticaria | 87.9 |
Chemical structure
| Molecular formula | C35H54GdN7O15 |
|---|---|
| Molecular weight | 970.10 g/mol |
| CAS number | 933983-75-6 |
| InChIKey | BVEYRIUDZCWBRJ-UHFFFAOYSA-L |
| PubChem CID | 16223405 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Gadopiclenol used for?
DrugCentral lists the following indications for Gadopiclenol: Detect and visualize lesions with abnormal vascularity with MRI.
When was Gadopiclenol first approved?
Gadopiclenol was first approved by the FDA in 2022.
What is the chemical formula of Gadopiclenol?
Gadopiclenol has the molecular formula C35H54GdN7O15 and a molecular weight of 970.10 g/mol.
Browse: all drugs starting with G · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 5681 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL4297634 — compound record and bioactivity
- PubChem CID 16223405 — chemical identifiers
- DrugBank DB17084 — drug record
- FDA UNII S276568KOY — substance identity
- DailyMed: FDA labels for Gadopiclenol — current prescribing information (label search)
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.